Jundishapur Journal of Microbiology

Published by: Kowsar

The First Macrolide-Resistant Bordetella pertussis Strains Isolated From Iranian Patients

Fereshteh Shahcheraghi 1 , * , Masoumeh Nakhost Lotfi 1 , Vajiheh Sadat Nikbin 1 , Fahimeh Shooraj 1 , Reza Azizian 1 , Masoumeh Parzadeh 1 , Mohammad Reza Allahyar Torkaman 1 and Seyed Mohsen Zahraei 2
Authors Information
1 Department of Bacteriology, Pertussis Reference Laboratory, Microbiology Research Center, Pasteur Institute of Iran, Tehran, IR Iran
2 Center for Communicable Diseases Control, Ministry of Health and Medical Education, Tehran, IR Iran
Article information
  • Jundishapur Journal of Microbiology: June 01, 2014, 7 (6); e10880
  • Published Online: June 1, 2014
  • Article Type: Research Article
  • Received: March 5, 2013
  • Revised: June 16, 2013
  • Accepted: June 25, 2013
  • DOI: 10.5812/jjm.10880

To Cite: Shahcheraghi F, Nakhost Lotfi M, Nikbin V S, Shooraj F, Azizian R, et al. The First Macrolide-Resistant Bordetella pertussis Strains Isolated From Iranian Patients, Jundishapur J Microbiol. 2014 ; 7(6):e10880. doi: 10.5812/jjm.10880.

Abstract
Copyright © 2014, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods and Materials
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Cherry JD. Epidemiology of pertussis. Pediatr Infect Dis J. 2006; 25(4): 361-2[DOI][PubMed]
  • 2. Mooi FR, van Oirschot H, Heuvelman K, van der Heide HG, Gaastra W, Willems RJ. Polymorphism in the Bordetella pertussis virulence factors P.69/pertactin and pertussis toxin in The Netherlands: temporal trends and evidence for vaccine-driven evolution. Infect Immun. 1998; 66(2): 670-5[PubMed]
  • 3. Mooi FR. Bordetella pertussis and vaccination: the persistence of a genetically monomorphic pathogen. Infect Genet Evol. 2010; 10(1): 36-49[DOI][PubMed]
  • 4. Wood N, McIntyre P. Pertussis: review of epidemiology, diagnosis, management and prevention. Paediatr Respir Rev. 2008; 9(3): 201-11[DOI][PubMed]
  • 5. Bamberger ES, Srugo I. What is new in pertussis? Eur J Pediatr. 2008; 167(2): 133-9[DOI][PubMed]
  • 6. Crowcroft NS, Pebody RG. Recent developments in pertussis. Lancet. 2006; 367(9526): 1926-36[DOI][PubMed]
  • 7. Lewis K, Saubolle MA, Tenover FC, Rudinsky MF, Barbour SD, Cherry JD. Pertussis caused by an erythromycin-resistant strain of Bordetella pertussis. Pediatr Infect Dis J. 1995; 14(5): 388-91[PubMed]
  • 8. Bartkus JM, Juni BA, Ehresmann K, Miller CA, Sanden GN, Cassiday PK, et al. Identification of a mutation associated with erythromycin resistance in Bordetella pertussis: implications for surveillance of antimicrobial resistance. J Clin Microbiol. 2003; 41(3): 1167-72[PubMed]
  • 9. Guillot S, Descours G, Gillet Y, Etienne J, Floret D, Guiso N. Macrolide-resistant Bordetella pertussis infection in newborn girl, France. Emerg Infect Dis. 2012; 18(6): 966-8[DOI][PubMed]
  • 10. Korgenski EK, Daly JA. Surveillance and detection of erythromycin resistance in Bordetella pertussis isolates recovered from a pediatric population in the Intermountain West region of the United States. J Clin Microbiol. 1997; 35(11): 2989-91[PubMed]
  • 11. Wilson KE, Cassiday PK, Popovic T, Sanden GN. Bordetella pertussis isolates with a heterogeneous phenotype for erythromycin resistance. J Clin Microbiol. 2002; 40(8): 2942-4[PubMed]
  • 12. Yao SM, Liaw GJ, Chen YY, Yen MH, Chen YH, Mu JJ, et al. Antimicrobial susceptibility testing of Bordetella pertussis in Taiwan prompted by a case of pertussis in a paediatric patient. J Med Microbiol. 2008; 57: 1577-80[DOI][PubMed]
  • 13. Ohtsuka M, Kikuchi K, Shimizu K, Takahashi N, Ono Y, Sasaki T, et al. Emergence of quinolone-resistant Bordetella pertussis in Japan. Antimicrob Agents Chemother. 2009; 53(7): 3147-9[DOI][PubMed]
  • 14. Advani A, Donnelly D, Hallander H. Reference system for characterization of Bordetella pertussis pulsed-field gel electrophoresis profiles. J Clin Microbiol. 2004; 42(7): 2890-7[DOI][PubMed]
  • 15. Advani A, Van der Heide HG, Hallander HO, Mooi FR. Analysis of Swedish Bordetella pertussis isolates with three typing methods: characterization of an epidemic lineage. J Microbiol Methods. 2009; 78(3): 297-301[DOI][PubMed]
  • 16. Bisgard KM, Christie CD, Reising SF, Sanden GN, Cassiday PK, Gomersall C, et al. Molecular epidemiology of Bordetella pertussis by pulsed-field gel electrophoresis profile: Cincinnati, 1989-1996. J Infect Dis. 2001; 183(9): 1360-7[DOI][PubMed]
  • 17. Nikbin VS, Shahcheraghi F, Lotfi MN, Zahraei SM, Parzadeh M. Comparison of culture and real-time PCR for detection of Bordetella pertussis isolated from patients in Iran. Iran J Microbiol. 2013; 5(3): 209-14[PubMed]
  • 18. Shahcheraghi F, Nakhost Lotfi M, Parzadeh M, Nikbin VS, Shouraj F, Zahraei S. [Isolation of Bordetella Pertussis and Bordetella Parapertussis from Clinical Specimens at Different Provinces]. J Mazandaran Univ Med Sci. 2012; 22(88): 2-8
  • 19. Koneman EW. Koneman's color Atlas and Textbook of diagnostic microbiology. 2006;
  • 20. McGowan KL. Clinical microbiology procedures handbook. 2004;
  • 21. Performance standards for antimicrobial susceptibility testing; eighteenth informational supplement 2010;
  • 22. Hill BC, Baker CN, Tenover FC. A simplified method for testing Bordetella pertussis for resistance to erythromycin and other antimicrobial agents. J Clin Microbiol. 2000; 38(3): 1151-5[PubMed]
  • 23. Hoppe JE, Bryskier A. In vitro susceptibilities of Bordetella pertussis and Bordetella parapertussis to two ketolides (HMR 3004 and HMR 3647), four macrolides (azithromycin, clarithromycin, erythromycin A, and roxithromycin), and two ansamycins (rifampin and rifapentine). Antimicrob Agents Chemother. 1998; 42(4): 965-6[PubMed]
  • 24. Langley JM, Halperin SA, Boucher FD, Smith B. Azithromycin is as effective as and better tolerated than erythromycin estolate for the treatment of pertussis. Pediatrics. 2004; 114(1)-101[PubMed]
  • 25. Tanaka H, Kaji M, Higuchi K, Shinohara N, Norimatsu M, Kawazoe H, et al. Problems associated with prophylactic use of erythromycin in 1566 staff to prevent hospital infection during the outbreak of pertussis. J Clin Pharm Ther. 2009; 34(6): 719-22[DOI][PubMed]
  • 26. Chodorowska M, Kuklinska D, Tyski S. [Susceptibility to macrolide antibiotics of Bordetella pertussis and Bordetella parapertussis strains isolated from whooping cough patients in 1968 and in 1997-99]. Med Dosw Mikrobiol. 2001; 53(1): 39-43[PubMed]
  • 27. Fry NK, Duncan J, Vaghji L, George RC, Harrison TG. Antimicrobial susceptibility testing of historical and recent clinical isolates of Bordetella pertussis in the United Kingdom using the Etest method. Eur J Clin Microbiol Infect Dis. 2010; 29(9): 1183-5[DOI][PubMed]
  • 28. Sintchenko V, Brown M, Gilbert GL. Is Bordetella pertussis susceptibility to erythromycin changing? MIC trends among Australian isolates 1971-2006. J Antimicrob Chemother. 2007; 60(5): 1178-9[DOI][PubMed]
  • 29. Hoppe JE, Halm U, Hagedorn HJ, Kraminer-Hagedorn A. Comparison of erythromycin ethylsuccinate and co-trimoxazole for treatment of pertussis. Infection. 1989; 17(4): 227-31[PubMed]
  • 30. Weisblum B. Erythromycin resistance by ribosome modification. Antimicrob Agents Chemother. 1995; 39(3): 577-85[PubMed]
  • 31. Mooi FR, Hallander H, Wirsing von Konig CH, Hoet B, Guiso N. Epidemiological typing of Bordetella pertussis isolates: recommendations for a standard methodology. Eur J Clin Microbiol Infect Dis. 2000; 19(3): 174-81[PubMed]
  • 32. Lin YC, Yao SM, Yan JJ, Chen YY, Hsiao MJ, Chou CY, et al. Molecular epidemiology of Bordetella pertussis in Taiwan, 1993-2004: suggests one possible explanation for the outbreak of pertussis in 1997. Microbes Infect. 2006; 8(8): 2082-7[DOI][PubMed]
  • 33. Goncalves CR, Vaz TM, Medeiros MI, Castro MT, Rocha MM, Melles CE, et al. Phenotypical and genotypical characterization of Bordetella pertussis strains isolated in Sao Paulo, Brazil, 1988-2002. Rev Inst Med Trop Sao Paulo. 2007; 49(2): 123-5[PubMed]
  • 34. Hallander H, Advani A, Riffelmann M, von Konig CH, Caro V, Guiso N, et al. Bordetella pertussis strains circulating in Europe in 1999 to 2004 as determined by pulsed-field gel electrophoresis. J Clin Microbiol. 2007; 45(10): 3257-62[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments